Malnutrition is common in systemic sclerosis: Results from the Canadian Scleroderma Research Group database

Journal of Rheumatology

Volumn 36, Issue 12, 2009, Pages 2737-2743

  Baron, Murray ^a   Hudson, Marie ^a   Steele, Russell ^a   Pope, J ^b   Markland, J ^b   Robinson, D ^b   Khalidi, N ^b   Jones, N ^b   Masetto, A ^b   Kaminska, E ^b   Docherty, P ^b   Mathieu, J P ^b   Sutton, E ^b   Abu Hakima, M ^b   LeClercq, S ^b   Smith, D ^b   Ligier, S ^b   Fritzler, M ^c  

^a MCGILL UNIVERSITY   (Canada)

^b Advanced Diagnostics Laboratory ^*

^c Advanced Diagnostics Laboratory   (Canada)

Author keywords

Malnutrition; Risk factors; Systemic sclerosis

Indexed keywords

HEMOGLOBIN;

ABDOMINAL DISTENSION; ADULT; ARTICLE; BODY MASS; CANADA; CLINICAL ASSESSMENT; CLINICAL TRIAL; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL SYMPTOM; HEMOGLOBIN DETERMINATION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALABSORPTION; MALE; MALNUTRITION; MULTICENTER STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SCLERODERMA; SCORING SYSTEM; SCREENING TEST; SYSTEMIC SCLEROSIS; XEROSTOMIA;

EID: 72449128694     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090694     Document Type: Article

References (51)

1. Cossio M, Menon Y, Wilson W, deBoisblanc BP. Life-threatening complications of systemic sclerosis. Crit Care Clin 2002;18:819-839
2. Parodi A, Sessarego M, Greco A, et al. Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. Am J Gastroenterol 2008;103:1257-1262 (Pubitemid 351677970)
3. Ebert EC. Gastric and enteric involvement in progressive systemic sclerosis. J Clin Gastroenterol 2008;42:5-12.
4. Nishimagi E, Tochimoto A, Kawaguchi Y, et al. Characteristics of patients with early systemic sclerosis and severe gastrointestinal tract involvement. J Rheumatol 2007;34:2050-2055 (Pubitemid 47548209)
5. Kaye SA, Lim SG, Taylor M, Patel S, Gillespie S, Black CM. Small bowel bacterial overgrowth in systemic sclerosis: detection using direct and indirect methods and treatment outcome. Br J Rheumatol 1995;34:265-269
6. Jaovisidha K, Csuka ME, Almagro UA, Soergel KH. Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature. Semin Arthritis Rheum 2005;34:689-702. (Pubitemid 40193368)
7. Ng SC, Clements PJ, Berquist WE, Furst DE, Paulus HE. Home central venous hyperalimentation in fifteen patients with severe scleroderma bowel disease. Arthritis Rheum 1989;32:212-216
8. Levien DH, Fiallos F, Barone R, Taffet S. The use of cyclic home hyperalimentation for malabsorption in patients with scleroderma involving the small intestines. JPEN J Parenter Enteral Nutr 1985;9:623-625 (Pubitemid 15019130)
9. Grabowski G, Grant JP. Nutritional support in patients with systemic scleroderma. JPEN J Parenter Enteral Nutr 1989;13:147-151 (Pubitemid 19096626)
10. Brown M, Teubner A, Shaffer J, Herrick AL. Home parenteral nutrition - an effective and safe long-term therapy for systemic sclerosis-related intestinal failure. Rheumatology 2008;47:176-179 (Pubitemid 351168227)
11. Cohen S. The gastrointestinal manifestations of scleroderma: pathogenesis and management. Gastroenterology 1980;79:155-166
12. Lundberg AC, Akesson A, Akesson B. Dietary intake and nutritional status in patients with systemic sclerosis. Ann Rheum Dis 1992;51:1143-1148
13. Herrick AL, Worthington H, Rieley F, et al. Dietary intake of micronutrient antioxidants in relation to blood levels in patients with systemic sclerosis. J Rheumatol 1996;23:650-653 (Pubitemid 26135136)
14. Stratton RJ, Hackston A, Longmore D, et al. Malnutrition in hospital outpatients and inpatients: prevalence, concurrent validity and ease of use of the 'malnutrition universal screening tool' ('MUST') for adults. Br J Nutr 2004;92:799-808.
15. Elia M. Screening for malnutrition: A multidisciplinary responsibility. Development and use of the 'malnutrition universal screening tool' ('MUST') for adults. Malnutrition Advisory Group (MAG), a Standing Committee of British Association for Parenteral and Enteral Nutrition. Redditch: BAPEN; 2003.
16. Medsger TA Jr, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W. Assessment of disease severity and prognosis. Clin Exp Rheumatol 2003;21:S42-6.
17. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-205 (Pubitemid 18073738)
18. Khanna D, Furst DE, Clements PJ, et al. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. J Rheumatol 2005;32:832-840 (Pubitemid 40676492)
19. Khanna D, Clements PJ, Furst DE, Chon Y, Elashoff R, Roth MD, et al. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Arthritis Rheum 2005;52:592-600.
20. Khanna D, Yan X, Tashkin DP, Furst DE, Elashoff R, Roth MD, et al. Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study. Arthritis Rheum 2007;56:1676-1684
21. Khanna D, Hays RD, Park GS, Braun-Moscovici Y, Mayes MD, McNearney TA, et al. Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument. Arthritis Rheum 2007;57:1280-1286 (Pubitemid 47585475)
22. Tashkin DP, Elashoff R, Clements PJ, Roth MD, Furst DE, Silver RM, et al. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med 2007;176:1026-1034
23. Avouac J, Sordet C, Depinay C, Ardizonne M, Vacher-Lavenu MC, Sibilia J, et al. Systemic sclerosis-associated Sjogren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum 2006;54:2243-2249 (Pubitemid 44051082)
24. Van Tubergen A, Debats I, Ryser L, Londono J, Burgos-Vargas R, Cardiel MH, et al. Use of a numerical rating scale as an answer modality in ankylosing spondylitis-specific questionnaires. Arthritis Rheum 2002;47:242-248 (Pubitemid 34627690)
25. Ferraz MB, Quaresma MR, Aquino LR, Atra E, Tugwell P, Goldsmith CH. Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis. J Rheumatol 1990;17:1022-1024 (Pubitemid 20278017)
26. Furst DE, Clements PJ, Steen VD, Medsger TA Jr, Masi AT, D'Angelo WA, et al. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol 1998;25:84-88
27. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-590
28. Health Canada. Canadian guidelines for body weight classification in adults. Ottawa: Health Canada; 2003.
29. Russell C, Elia M. Nutrition screening survey in the UK in 2007: A report by BAPEN, British Association for Parenteral and Enteral Nutrition. [Internet. Accessed Sept 1, 2009.] Availabile from: http://www.bapen.org.uk/res-pub.html.
30. Stafford-Brady FJ, Kahn HJ, Ross TM, Russell ML. Advanced scleroderma bowel: complications and management. J Rheumatol 1988;15:869-874
31. Elia M, Zellipour L, Stratton RJ. To screen or not to screen for adult malnutrition? Clin Nutr 2005;24:867-884
32. Jones JM. Validity of nutritional screening and assessment tools. Nutrition 2004;20:312-317 (Pubitemid 38264388)
33. Jones JM. The methodology of nutritional screening and assessment tools. J Hum Nutr Diet 2002;15:59-71; quiz 3-5.
34. Kondrup J, Allison SP, Elia M, Vellas B, Plauth M. ESPEN guidelines for nutrition screening 2002. Clin Nutr 2003;22:415-421
35. Baker JP, Detsky AS, Wesson DE, Wolman SL, Stewart S, Whitewell J, et al. Nutritional assessment: a comparison of clinical judgement and objective measurements. N Engl J Med 1982;306:969-972
36. Detsky AS, Smalley PS, Chang J. The rational clinical examination. Is this patient malnourished? JAMA 1994;271:54-58
37. Elkan AC, Engvall IL, Tengstrand B, Cederholm T, Hafstrom I. Malnutrition in women with rheumatoid arthritis is not revealed by clinical anthropometrical measurements or nutritional evaluation tools. Eur J Clin Nutr 2008;62:1239-1247
38. Gerasimidis K, Drongitis P, Murray L, Young D, McKee RF. A local nutritional screening tool compared to malnutrition universal screening tool. Eur J Clin Nutr 2007;61:916-921 (Pubitemid 47040316)
39. Sieber CC. Nutritional screening tools - How does the MNA compare? Proceedings of the session held in Chicago May 2-3, 2006 (15 Years of Mini Nutritional Assessment). J Nutr Health Aging 2006;10:488-92; discussion 92-94
40. Kyle UG, Kossovsky MP, Karsegard VL, Pichard C. Comparison of tools for nutritional assessment and screening at hospital admission: a population study. Clin Nutr 2006;25:409-417 (Pubitemid 43843018)
41. Godfrey K. Implementation of the Malnutrition Universal Screening Tool. Nurs Times 2004;100:61.
42. Malnutrition Advisory Group. A consistent and reliable tool for malnutrition screening. Nurs Times 2003;99:26-27
43. Stratton RJ, King CL, Stroud MA, Jackson AA, Elia M. 'Malnutrition Universal Screening Tool' predicts mortality and length of hospital stay in acutely ill elderly. Br J Nutr 2006;95:325-330
44. Elia M, Ward LC. New techniques in nutritional assessment: body composition methods. Proc Nutr Soc 1999;58:33-38 (Pubitemid 29225544)
45. King C, Elia M, Stroud M, Stratton R. The predictive validity of the malnutrition universal screening tool ('MUST') with regard to mortality and length of stay in elderly inpatients. Clin Nutr 2003;22:S4.
46. Wood C, Stubbs S, Warwick H, Dunnachie A, Elia M, Stratton R. Malnutrition risk and health care utilisation in orthopaedic patients. Proc Nutr Soc 2004;63:20A.
47. Stratton R, Thompson R, Margetts B, Stroud M, Jackson A, Elia M. Health care utilisation according to malnutrition risk in the elderly: an analysis of data from the National Diet and Nutrition Survey. Proc Nutr Soc 2002;61:20A.
48. Medsger TA Jr. Assessment of damage and activity in systemic sclerosis. Curr Opin Rheumatol 2000;12:545-548 (Pubitemid 30803632)
49. Baron M, Sutton E, Hudson M, Thombs B, Markland J, Pope J, et al. The relationship of dyspnoea to function and quality of life in systemic sclerosis. Ann Rheum Dis 2008;67:644-650 (Pubitemid 351571928)
50. Hudson M, Taillefer S, Steele R, et al. Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis. Clin Exp Rheumatol 2007;25:754-757 (Pubitemid 350284851)
51. Hudson M, Thombs BD, Steele R, Watterson R, Taillefer S, Baron M. Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disability Assessment Schedule II. Arthritis Rheum 2008;59:279-284 (Pubitemid 351272966)